Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenal
Clara S. Mundry, Kirsten C. Eberle, Pankaj K. Singh, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 1, pp. 188387-188387
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Pyroptosis: a new paradigm of cell death for fighting against cancer
Yixin Tan, Quanzhu Chen, Xiaoling Li, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 356
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
Luman Liu, Prakash Kshirsagar, Shailendra K. Gautam, et al.
Theranostics (2022) Vol. 12, Iss. 3, pp. 1030-1060
Open Access | Times Cited: 82
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39
Metformin boosts antitumor immunity and improves prognosis in upfront resected pancreatic cancer: an observational study
Casper W.F. van Eijck, Disha Vadgama, Casper H.J. van Eijck, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 8, pp. 1374-1383
Open Access | Times Cited: 10
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma
Takeshi Tanaka, Atsuhiro Masuda, Jun Inoue, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 3, pp. 277-291
Closed Access | Times Cited: 20
The role of pyroptosis in modulating the tumor immune microenvironment
Jinxiang Wu, Lei Wang, Jianwei Xu
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Targeting the pancreatic tumor microenvironment by plant-derived products and their nanoformulations
Mohamed J. Saadh, Mohammed Ahmed Mustafa, H. Malathi, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 5
miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer
Chengzhi Wang, Xin Li, Lijuan Zhang, et al.
International Immunopharmacology (2021) Vol. 97, pp. 107822-107822
Open Access | Times Cited: 31
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
Nicholas J. Mullen, Surendra K. Shukla, Ravi Thakur, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 11
HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis
Alpha Raj Mekapogu, Zhihong Xu, Srinivasa Pothula, et al.
Cancer Letters (2023) Vol. 568, pp. 216286-216286
Open Access | Times Cited: 11
Pigmented intratarsal keratinous cyst with polymicrobial colonization
Christian J. Goguen, Patrick Daigle
Canadian Journal of Ophthalmology (2025)
Closed Access
DAMPs prognostic signature predicts tumor immunotherapy, and identifies immunosuppressive mechanism of pannexin 1 channels in pancreatic ductal adenocarcinoma
Qianxue Wu, Qian Xiao, Xin Tang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Histamine 1 Receptor (HRH1): A potential therapeutic target for Pancreatic Ductal Adenocarcinoma
Cristina Salmerón, Elena Tomás Bort, Krishna Bajee Sriram, et al.
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103573-103573
Open Access
Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer
Max Heiduk, Ioana Plesca, Jessica M. Gluck, et al.
JCI Insight (2022) Vol. 7, Iss. 22
Open Access | Times Cited: 17
The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway
Qing Li, Jialuo He, Senlin Li, et al.
Clinical Immunology (2022) Vol. 248, pp. 109217-109217
Closed Access | Times Cited: 14
Positron emission tomography molecular imaging to monitor anti-tumor systemic response for immune checkpoint inhibitor therapy
Xiaoqing Xing, Qing Zhao, Jinyun Zhou, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 6, pp. 1671-1688
Open Access | Times Cited: 8
Chondroitin Sulfate and Fucosylated Chondroitin Sulfate as Stimulators of Hematopoiesis in Cyclophosphamide-Induced Mice
Nadezhda E. Ustyuzhanina, N. Yu. Anisimova, Maria I. Bilan, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1074-1074
Open Access | Times Cited: 18
Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments
Marzia Conte, Valentina Cauda
Advanced Therapeutics (2022) Vol. 5, Iss. 11
Open Access | Times Cited: 13
In-vitro model to mimic T cell subset change in human PDAC organoid co-culture
Margit Knoblauch, Tao Ma, Iris Beirith, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 13051-13064
Open Access | Times Cited: 7
New avenues for the treatment of immunotherapy-resistant pancreatic cancer
Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1134-1153
Open Access | Times Cited: 2
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
Nicholas J. Mullen, Surendra K. Shukla, Ravi Thakur, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 2
LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis
Pankaj K. Singh, Kamiya Mehla
Cancer Research (2023) Vol. 83, Iss. 11, pp. 1759-1761
Open Access | Times Cited: 6
Cellular Membrane Localization of Innate Immune Checkpoint Molecule CD47 Is Regulated by Radixin in Human Pancreatic Ductal Adenocarcinoma Cells
Takuro Kobori, Yui Ito, Yuka Sawada, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1117-1117
Open Access | Times Cited: 5
The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer
Sherise C. Rogers, Angel Charles, Ryan M. Thomas
Cancers (2023) Vol. 15, Iss. 24, pp. 5708-5708
Open Access | Times Cited: 5
Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma
M Kellis, Wanting Hou, Chaoxin Xiao, et al.
Cellular Oncology (2024) Vol. 47, Iss. 5, pp. 1561-1578
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top